{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:59:52Z","timestamp":1785207592785,"version":"3.55.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejim.2025.106637","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T04:48:41Z","timestamp":1765255721000},"page":"106637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Is left ventricular hypertrophy a reliable predictor of renal and cardiac outcome in IgA nephropathy?"],"prefix":"10.1016","volume":"145","author":[{"given":"Ernesto","family":"Paoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bussalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.106637_bib0001","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease","volume":"18","author":"Matsushita","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2025.106637_bib0002","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.ajkd.2005.04.031","article-title":"Left ventricular hypertrophy in nondiabetic predialysis CKD","volume":"46","author":"Paoletti","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2025.106637_bib0003","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1681\/ASN.2012020145","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study Group. Associations between kidney function and subclinical cardiac abnormalities in CKD","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"25 Suppl 1","key":"10.1016\/j.ejim.2025.106637_bib0004","article-title":"Surrogate markers for cardiovascular disease: structural markers","volume":"109","author":"Mancini","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.106637_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2215\/CJN.06980615","article-title":"Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension","volume":"11","author":"Paoletti","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2025.106637_bib0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41581-018-0101-8","article-title":"Evolving concepts in the pathogenesis of uraemic cardiomyopathy","volume":"15","author":"Wang","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2025.106637_bib0007","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2025.106637_bib0008","article-title":"Left ventricular remodeling in IgA nephropathy - clinical applicability and lessons from real-world practice","volume":"4","author":"Wang","year":"2025","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2025.106637_bib0009","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/HYPERTENSIONAHA.107.093120","article-title":"Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension","volume":"50","author":"Salles","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2025.106637_bib0010","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1681\/ASN.2009060631","article-title":"Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD","volume":"20","author":"Eckardt","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2025.106637_bib0011","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.numecd.2020.07.038","article-title":"Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy","volume":"30","author":"Russo","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ejim.2025.106637_bib0012","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052500514X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052500514X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:28:25Z","timestamp":1785205705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362052500514X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":12,"alternative-id":["S095362052500514X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106637","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is left ventricular hypertrophy a reliable predictor of renal and cardiac outcome in IgA nephropathy?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106637"}}